Carboxylated Graphene Oxide–Curcumin Nanoadducts: Physicochemical Characterization, Cytocompatibility, MCF-7 Cytotoxicity, and Preliminary Local Tissue Response

Graphene oxide (GO) offers a high-surface-area platform for the noncovalent association of hydrophobic bioactive compounds, but its biological response depends strongly on surface chemistry. Here, GO was carboxylated with sodium chloroacetate and physically associated with curcumin (CUR) to obtain a graphene oxide–curcumin nanoadduct (GO-COOH-CUR). Ultraviolet-visible spectroscopy (UV-vis), X-ray photoelectron spectroscopy (XPS), Raman spectroscopy, Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and atomic force microscopy (AFM) were used to assess chemical and morphological changes. XPS showed a lower C/O ratio and a higher fitted O-C=O contribution after carboxylation, although residual Na and Cl were detected. UV-vis, FTIR and XPS features were consistent with the presence of curcumin in the formulation with 83.35% of encapsulation efficiency (EE). In 24 h MTT assays, CO-COOH-CUR maintained BHK-21 metabolic activity above 70% across 3.125 µg mL−1 and reduced MCF-7 metabolic activity at the higher tested concentrations. Because formulation concentrations were expressed as a total mass and curcumin concentration is not reported here, direct potency or selectivity comparisons with free curcumin were not made. Qualitative histological evaluation performed 30 days after subdermal implantation in three male Wistar rats showed preserved adjacent tissue architecture, with no evident necrosis, prominent inflammatory infiltrate, organized fibrous capsule, or foreign-body giant cell response in the sections evaluated. These findings support further evaluation of GO-COOH-CUR within the limits of MTT-based and qualitative assessment.